The Venture Codex

Participated · Equity · Mar 2024

Vitas, founded in 2018 by Thomas Abend, René Straub and Tobias Bäumler, builds a no-code platform enabling companies to configure bespoke AI telephone assistants. The platform is positioned to let customers create individualized, AI-based telephone support without coding. The team says the new funding will be used primarily to expand the team and to continuously improve the platform. The company is based in Nuremberg and targets businesses seeking automated voice-assistant solutions. No operating metrics (revenue/users) are disclosed in the article.

Participated · Equity · Feb 2024

Founded in 2016 and based in Krakow, Poland, edrone builds an autonomous e-commerce customer-relationship management platform that combines marketing automation and voice commerce. Its platform collects, processes, and triggers customer data to understand behavior and engage shoppers. The system is used by nearly 2,000 online stores, primarily in Poland and Brazil. edrone says it doubled its revenue in Brazil in 2023. The company plans to use new funding to expand operations in Brazil, improve business processes in Poland, and invest in product development to better leverage AI-supported marketing automation. In February 2024 edrone raised €4.6M to support these initiatives.

Participated · Seed · Sep 2022

DoxyChain builds infrastructure that blends traditional document frontends with Web 3.0 features to improve security, transparency, and workflow automation. The company is developing a modular platform that lets clients create tailored advanced workflows and smart-contract–driven process automation. In October the firm plans to launch DoxyCert, a toolkit for issuing blockchain certificates (including NFTs) as proof of authenticity or ownership, and DoxyConnect, a blockchain-built data-room for secure document exchange. The startup says its economic value centers on process automation via smart contracts so developers can focus on UX while DoxyChain handles decentralization and automation. DoxyChain raised fresh capital to accelerate product development and support expansion into European and U.S. markets.

Participated · Equity · Jun 2019

Infermedica is a Poland-founded digital health company that offers a B2B AI-powered Medical Guidance Platform for symptom analysis, preliminary diagnosis and patient triage. Its platform automates patient triage, intake and post-visit follow-up for health systems, payers and providers and includes a symptom checker, an AI tool to support call operators and an API for custom diagnostic solutions. The product is used in more than 30 countries, available in 19 languages, and has completed over 10 million health checks. The company intends to develop new modules to cover the full primary care journey and to expand its underlying AI disease coverage and accuracy. Commercially, Infermedica plans to strengthen its position in the U.S. and DACH and will focus the majority of its sales and marketing efforts there. The team grew 80% to 180 specialists last year and the company expects to nearly double headcount in the next 12 months. Infermedica provides an AI-driven, API-first platform for symptom checking, preliminary diagnosis and patient triage, sold primarily to insurers, telemedicine providers and health systems on a B2B basis. The product is white-labeled for customers and integrates with chatbots, patient portals and EHRs; Microsoft has integrated the platform into its health bot. The company reports nearly 40,000 hours of physician work contributed and 6,000,000 completed user checkups across its platform. Infermedica licenses its technology on a SaaS basis, charging by API calls or completed patient checkups. Management says new funds will be used for platform R&D to enhance triage, symptom-checking and clinical decision support. The company plans to expand operations in Germany and the U.S. Infermedica builds an AI-driven symptom checker that asks users follow-up questions and helps guide patients to appropriate care options such as virtual follow-up, urgent care, or the emergency room. The company trains its algorithm using curated medical literature and external datasets, supported by a medical team of about 20 people and over 20,000 hours of literature curation. In addition to the symptom checker, Infermedica offers call-center triage services and a medical API as white-label solutions for insurers, hospital systems, and health IT companies. Founded in Poland in 2012, the startup pivoted from a direct-to-consumer model to a B2B model to improve monetization. It plans to implement a closed-loop system to continuously learn from anonymized patient interactions and physician diagnoses. The company has recently expanded into the United States and is hiring US roles, including head of sales and head of marketing. Financially, Infermedica disclosed a new $3.65 million funding round to support product development and its US expansion.

Participated · Series A · Aug 2017

WhatsBroadcast provides messenger marketing and enterprise messenger services, offering the infrastructure and tools for WhatsApp, Facebook Messenger, Telegram and Insta. Its core competency is messenger marketing and interactive chatbots that enable automated 1:1 communication for customer support, shopping, information requests, and entertainment. The company delivers its product via a Software as a Service license model with a browser interface to control messenger marketing, customer support and interactive chatbots. Started in spring 2015 and based in Munich, it supports over 800 companies and employs about 30 people, serving many German-speaking clients and a growing number of international customers. Its solutions are designed to operate efficiently and in compliance with privacy regulations. The company intends to use the funds to grow its international business, especially around chatbots.